GLP-1 receptor agonist Clinical Trials
8 recruitingDrug
Phase 42Phase 22Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 2
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Cerebral Small Vessel Disease
Chinese University of Hong Kong110 enrolled2 locationsNCT05356104
Recruiting
Phase 2
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Obesity in childrenObesityLifestyle Modification+3 more
University of Virginia120 enrolled1 locationNCT06903923
Recruiting
Phase 4
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Type2diabetesASCVD
Brigham and Women's Hospital6,000 enrolled36 locationsNCT05390892
Recruiting
Phase 4
Impact GLP-1 Agonists Following Bariatric
Diabetes MellitusMetabolic SyndromeHypertension+2 more
University of Missouri-Columbia150 enrolled1 locationNCT06132477
Recruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
ObesityDiabetes Mellitus, Type 2Chronic Kidney Disease stage3+3 more
Cardenal Herrera University250 enrolled1 locationNCT07309094
Recruiting
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS
HyperinsulinismMetabolic SyndromePCOS+1 more
Attikon Hospital120 enrolled1 locationNCT06889454
Recruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Obesity
Vanderbilt University Medical Center60 enrolled1 locationNCT07115069
Recruiting
Not Applicable
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM
Type 2 Diabetes MellitusSusceptibility, Genetic
The Affiliated Hospital of Xuzhou Medical University300 enrolled1 locationNCT06256419